Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood

HelixBind

Status: Unknown

Conditions: Candidemia; Bacteremia

Treatments: Diagnostic Test: RaPID/BSI Test

Study type: Observational

Funder types: Industry

Identifiers

NCT04147975

20031

Details and patient eligibility

About

The purpose of this study is to assess the effectiveness of RaPID/BSI by testing its performance compared to blood cultures collected prospectively from consented subjects.

Enrollment: 225 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Determined to have a positive blood culture.

Exclusion criteria

Trial design

225 participants in 1 patient group

Patients Suspected of Bloodstream Infection

Description:

No intervention(s) to be administered.

Treatment:

Diagnostic Test: RaPID/BSI Test